Steven allen eschrich
Researcher
Deparment of Biostatistics and Bioinformatics
Moffitt Cancer Center
United States of America
Biography
Dr. Steven Allen Eschrich is affiliated to Deparment of Biostatistics and Bioinformatics, Moffitt Cancer Center. Dr. Steven Allen Eschrich is currently providing services as Researcher. Dr. Steven Allen Eschrich has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Steven Allen Eschrich contributions have acclaimed recognition from honourable subject experts around the world. Dr. Steven Allen Eschrich is actively associated with different societies and academies. Dr. Steven Allen Eschrich academic career is decorated with several reputed awards and funding. Dr. Steven Allen Eschrich research interests include My research interests can be broadly categorized into two areas. First, I am interested in developing and adapting technology to answer biomedical questions more precisely or more robustly. My work in this area includes the development of software tools and algorithms for more accurately quantifying gene expression from microarray experiments. A second area of research interest involves the use of computational tools to elucidate more knowledge from high-throughput biological assays..
Research Interest
My research interests can be broadly categorized into two areas. First, I am interested in developing and adapting technology to answer biomedical questions more precisely or more robustly. My work in this area includes the development of software tools and algorithms for more accurately quantifying gene expression from microarray experiments. A second area of research interest involves the use of computational tools to elucidate more knowledge from high-throughput biological assays.
Publications
-
Stewart PA, Fang B, Slebos RJ, Zhang G, Borne AL, Fellows K, Teer JK, Chen Y, Welsh E, Eschrich SA, Haura EB. Relative protein quantification and accessible biology in lung tumor proteomes from four LCâ€MS/MS discovery platforms. Proteomics. 2017 Mar 1;17(6).
-
Li B, Eschrich SA, Berglund A, Mitchell M, Fenstermacher D, Danaee H, Dai H, Sullivan D, Trepicchio WL, Dalton WS. Use of the Total Cancer Care System to Enrich Screening for CD30-Positive Solid Tumors for Patient Enrollment Into a Brentuximab Vedotin Clinical Trial: A Pilot Study to Evaluate Feasibility. JMIR research protocols. 2017 Mar;6(3).
-
Teer JK, Zhang Y, Chen L, Welsh EA, Cress WD, Eschrich SA, Berglund AE. Evaluating somatic tumor mutation detection without matched normal samples. Human Genomics. 2017 Sep 4;11(1):22.
